For SynchroMed pump models 8615, 8616, 8617 and 8618 please refer to the MRI Information for the SynchroMed EL Pump.
Before any medical procedure is begun, patients must always inform any health care personnel that they have an implanted drug infusion system and share this information about MRI with them.
Models: SynchroMed® EL: All models beginning with 8626, 8627
Reference: SynchroMed IsoMed Information for Prescribers Manual
SynchroMed EL pump performance has not been established for greater than 3.0 Tesla (T) horizontal, closed-bore MRI scanners. SynchroMed EL pump performance has not been established using other types of MRI scanners such as open-sided or standing MRI.
The magnetic field of the MRI scanner will temporarily stop the rotor of the SynchroMed EL pump motor and suspend drug infusion for the duration of the MRI exposure. The pump should resume normal operation upon termination of MRI exposure; however, there is the potential for an extended delay in pump recovery after exiting the MRI magnetic field because exposure to the MRI magnetic field may cause the motor gears within the pump to bind temporarily without permanent damage. This is caused by the potential for backward rotation of the pump rotor magnet when it aligns with the MRI magnetic field. This temporary binding may delay the return of proper infusion after the pump is removed from the MRI magnetic field. While extended delays in pump recovery are unlikely, reports have indicated that there is the potential for a two to twenty-four hour delay in return to proper drug infusion after completion of an MRI scan.
Warning: Patients receiving intrathecal baclofen therapy (e.g. Lioresal Intrathecal) are at higher risk for adverse events, as baclofen withdrawal can lead to a life threatening condition if not treated promptly and effectively. For complete product information, refer to the Lioresal Intrathecal (baclofen injection) Package Insert. For information on other drugs, please refer to the product labeling for the drug being administered.
90° alignment of an implanted pump with the z axis (Figure 1) of 1.5 T and 3.0 T horizontal, closed-bore magnetic resonance imaging (MRI) scanners can cause MRI-induced demagnetization of the internal pump motor magnets, which can result in permanent, nonrecoverable stoppage of the pump. This is due to the orientation of the pump with respect to the magnetic field of a horizontal, closed-bore MRI system. SynchroMed EL pump performance has not been established using other types of MRI scanners such as open-sided or standing MRI.

Figure 1. Pump positions in relation to z-axis MRI orientations
Note: If the pump face is oriented at 90° to the z axis, the refill port would be facing towards the patient’s feet or head.
Prior to MRI, the physician should ensure the pump is not oriented 90° with respect to the z axis of the MRI scanner (see Figure 1). The physician should also determine if the patient implanted with a SynchroMed EL pump can safely be deprived of drug delivery. If the patient cannot be safely deprived of drug delivery, alternative delivery methods for the drug can be used during the time required for the MRI scan. If there is concern that depriving the patient of drug delivery may be unsafe for the patient during the MRI procedure, medical supervision should be provided while the MRI is conducted.
Note: Prior to the MRI scan, confirm that the pump program settings are documented in case reprogramming is required after the scan.
Upon completion of the MRI scan, or shortly thereafter, the SynchroMed EL pump must be interrogated using the clinician programmer in order to confirm that electromagnetic interference from the MRI has not affected the pump status. If interrogation using the clinician programmer shows that a “Pump Memory Error” occurred, the physician must reprogram the pump in order for proper drug infusion to resume. A Pump Memory Error Alarm (double tone) will accompany a Pump Memory Error. If this occurs, notify:
The SynchroMed EL pump does not detect or alarm for motor stalls. A physician should confirm a SynchroMed EL pump has resumed proper drug infusion after an MRI by performing a pump roller study. If a pump roller study cannot be performed, patients must be closely monitored for return of underlying symptoms to confirm the pump has resumed proper drug infusion after an MRI. The duration of monitoring depends on the drug and the delivery rate. Consult the patient's providing physician for likely time period for return of symptoms in the event of a pump stoppage.
Testing on the SynchroMed EL pump has established the following with regard to other MRI safety and diagnostic issues:
Models: SynchroMed® II: All models beginning with 8637
Reference: SynchroMed IsoMed Information for Prescribers Manual
SynchroMed II pump performance has not been established for greater than 3.0 Tesla (T) horizontal, closed-bore MRI scanners. SynchroMed II pump performance has not been established using other types of MRI scanners such as open-sided or standing MRI.
The magnetic field of the MRI scanner will temporarily stop the rotor of the SynchroMed II pump motor and suspend drug infusion for the duration of the MRI exposure. The pump should resume normal operation upon termination of MRI exposure; however, there is the potential for an extended delay in pump recovery after exiting the MRI magnetic field because exposure to the MRI magnetic field may cause the motor gears within the pump to bind temporarily without permanent damage. This is caused by the potential for backward rotation of the pump rotor magnet when it aligns with the MRI magnetic field. This temporary binding may delay the return of proper infusion after the pump is removed from the MRI magnetic field. While extended delays in pump recovery are unlikely, reports have indicated that there is the potential for a two to twenty-four hour delay in return to proper drug infusion after completion of an MRI scan.
Warning: Patients receiving intrathecal baclofen therapy (e.g. Lioresal Intrathecal) are at higher risk for adverse events, as baclofen withdrawal can lead to a life threatening condition if not treated promptly and effectively. For complete product information, refer to the Lioresal Intrathecal (baclofen injection) Package Insert. For information on other drugs, please refer to the product labeling for the drug being administered.
The SynchroMed II pump detects motor stall and motor stall recovery. Medtronic does not recommend programming the SynchroMed II pump to "stopped pump mode" prior to an MRI because of the possibility of an increased delay in the detection of an extended motor stall. Motor stall events are recorded in the pump event log and can be reviewed using the clinician programmer. A motor stall will also cause the pump alarm to sound (two tone alarm). The slower the programmed delivery rate, the longer it may take for the stall detection algorithm to log motor stall and motor stall recovery. For pumps programmed to deliver at least 0.048 ml/day, the motor stall detection (with audible alarm) should occur within 20 minutes of exposure to the MRI magnetic field. Stall recovery detection should occur within 20 minutes of exiting the MRI magnetic field. The detection of a motor stall and detection of motor stall recovery may each take up to 90 minutes if the pump is programmed to minimum rate mode (0.006 ml/day).
In some cases, electromagnetic interference (EMI) from an MRI scan can interfere with normal event logging. If this occurs, it may cause the pump to switch into the telemetry mode. 'Telemetry mode' is a special state in which the pump is able to communicate with the clinician programmer. While in this state, the pump infuses normally; however, some error logging and the audible alarm for motor stall are suspended. If the pump switches into telemetry mode due to EMI, the pump resumes drug delivery after leaving the MRI magnetic field; however, pump motor stall and motor stall recovery detection function is not active until the post-MRI pump interrogation ends telemetry mode (refer to "Post-MRI examination review"). Due to this issue, if the interrogation is not performed upon completion of the MRI scan or shortly thereafter, review of the pump logs may indicate that the pump ceased drug delivery for an extended period of time, when in fact it had recovered normally. In this scenario, you may receive an erroneous "stopped pump period may exceed tube set" error message.
Note: In some cases, the SynchroMed II pump event log may not register motor stall recovery until after the pump has been interrogated a second time due to the effect of electromagnetic interference on the pump.
90° alignment of an implanted pump with the z axis (Figure 2) of 1.5 T and 3.0 T horizontal, closed-bore magnetic resonance imaging (MRI) scanners can cause MRI-induced demagnetization of the internal pump motor magnets, which can result in permanent, nonrecoverable stoppage of the pump. This is due to the orientation of the pump with respect to the magnetic field of a horizontal, closed-bore MRI system. SynchroMed II pump performance has not been established using other types of MRI scanners such as open-sided or standing MRI.

Figure 2. Pump positions in relation to z-axis MRI orientations
Note: If the pump face is oriented at 90° to the z axis, the refill port would be facing towards the patient’s feet or head.
Prior to MRI, the physician should ensure the pump is not oriented 90° with respect to the z axis of the MRI scanner (see Figure 2). The physician should also determine if the patient implanted with a SynchroMed II pump can safely be deprived of drug delivery. If the patient cannot be safely deprived of drug delivery, alternative delivery methods for the drug can be used during the time required for the MRI scan. If there is concern that depriving the patient of drug delivery may be unsafe for the patient during the MRI procedure, medical supervision should be provided while the MRI is conducted.
Upon completion of the MRI scan, or shortly thereafter, the physician must confirm that therapy has properly resumed by interrogating the SynchroMed II pump with the clinician programmer. For pumps programmed to deliver at least 0.048 ml/day, the detection of the motor stall should occur within 20 minutes of MRI exposure.
Detection of the motor stall: Recovery and recording of the recovery in the pump event log will typically occur within 20 minutes of the removal of the pump from the MRI magnetic field.
Note: Both the detection of the motor stall and detection of the motor stall recovery may each take up to 90 minutes if the pump is programmed to minimum rate mode (0.006 ml/day). In the unlikely event that electromagnetic interference from the MRI scan causes a change to “safe state”, the pump will automatically switch to minimum rate mode (infusion at 0.006 ml/day). The pump must be reprogrammed in order for proper infusion to resume.
The following pump interrogation guidelines should be used to determine whether the pump has resumed proper function (refer to the SynchroMed II Programming Guide for information about how to interrogate the pump and view event logs).
Testing on the SynchroMed II pump has established the following with regard to other MRI safety and diagnostic issues:
Models: IsoMed®: All models beginning with 8472
Reference: SynchroMed IsoMed Information for Prescribers Manual
IsoMed pump performance has not been established in >1.5 Tesla (T) magnetic resonance scanners. Patients should not have magnetic resonance imaging (MRI) using >1.5 T scanners.
Exposure of IsoMed pumps to MRI fields of 1.5 T has demonstrated no impact on pump performance and a limited effect on the quality of the diagnostic information.
Testing on the IsoMed pump has established the following with regard to MRI safety and diagnostic issues: